Accretive Health (AH) plummets 30% after saying yesterday that its postponing its Q4 and FY...


Accretive Health (AH) plummets 30% after saying yesterday that its postponing its Q4 and FY earnings results. Raymond James suspends its rating, saying: "No visibility into future results, and are left with more questions than answers."
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs